Category: St. Jude Medical
Medtronic wins CE Mark approval in the European Union for its CapSure Sense SureScan pacing leads, the smallest MRI-safe pacemaker leads.
Medtronic (NYSE:MDT) won CE Mark approval in the European Union for its latest-generation MRI-friendly pacemaker lead set, the CapSure Sense MRI SureScan.
The leads are the smallest available in the world that allow patients to undergo MRI procedures without risking damage to their devices from the scanners' powerful magnets.
Families sue Synthes over patient deaths, St. Jude and Stryker tie for most admired company and former Medtronic CEO Hawkins chairs the new med-tech regulatory science research center.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
St. Jude and Stryker are neck and neck for the most admired medical equipment company, according to a survey by CNN Money.
MASSDEVICE ON CALL — St. Jude (NYSE:STJ) and Stryker (NYSE:SYK) tied for the top spot on this year's CNN Money Most Admired Companies list, generated by a survey circulated among businesspeople who ranked companies based on parameters such as financial soundness and social responsibility.
, Baxter International
, Becton Dickinson & Co.
, Boston Scientific
, C.R. Bard
, CareFusion Corp.
, St. Jude Medical
, 3M Corp.
The proportion of medical students who claim to know someone using prostitution to pay tuition has more than doubled in the last 10 years, according to a new study.
MASSDEVICE ON CALL — A growing number of students claim to know a peer who is using prostitution to pay for med school, according to a new study published in the British Medical Journal.
1 in 10 students surveyed claimed to know someone in the sex trade as a last resort for paying tuition, up from 6% of those surveyed in 2006 and 4% in 2002.
The board of directors for beleaguered Olympus Corp. resigns as 1, with the marketing director for its medical device business on tap to step in as president; also, analyst to Medtronic: Sell off the ICD and spine businesses; St. Jude raises dividend; DePuy ASR settlements could reach $1M – each; plus, a Deals Roundup, a Funding Roundup and analysts' ups and downs.
The new slate of directors for Olympus Corp. (TYO:7733) is already drawing fire from foreign investors in the endoscopy giant, after its entire board resigned en masse over a $1.7 billion accounting scandal that's slashed its valuation by about 50% since October.
, Cyberonics Inc.
, DePuy Synthes
, DexCom Inc.
, Dgimed Ortho
, Johnson & Johnson
, Marco Ophthalmic
, Osseon Therapeutics Inc.
, St. Jude Medical
, Tornier Inc.
, Aesculap Implant Systems LLC
By Westby G. Fisher, MD, FACC
Today, a remarkable tour de force essay on the St. Jude Medical Riata defibrillator lead recall controversy written by Edward J Schloss, MD, director of cardiac electrophysiology at Christ Hospital in Cincinnati, OH, appears at Cardiobrief.
CardioFocus treats the first patient in its pivotal trial of the HeartLight endoscopic ablation system for atrial fibrillation.
CardioFocus successfully treated the first patient in a pivotal trial of its HeartLight endoscopic ablation system for atrial fibrillation.
The HeartLight device is the first of its kind to to allow direct visualization of a beating heart in real time, without using radiation, to allow physicians to better aim delivery of ablation energy, according to a press release.